MARIMED INC. (MRMD)

↓ Download CSV

CIK 0001522767 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, MARIMED INC. reported revenue of $159.83M, up 1.3% from the prior year. The company ran a net loss, with a net margin of -9.1% and a gross margin of 36.2%. It held $202.56M in total assets against $137.83M in total liabilities.

Key ratios (FY2025)

36.2%
Gross margin
-1.8%
Operating margin
-9.1%
Net margin
-29.0%
Return on equity
+1.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$159.83M$157.71M$148.60M$134.01M$121.46M$50.90M$45.60M$11.85M$6.07M
Cost of Revenue$101.94M$95.10M$82.68M$70.05M$55.20M$19.57M$26.90M$4.04M$2.19M$1.35M
Gross Profit$57.88M$62.61M$65.92M$63.96M$66.26M$31.32M$18.70M$7.81M$3.88M$1.95M
Operating Income-$2.82M$2.61M$14.38M$20.37M$26.86M$14.53M-$41.53M-$5.36M$127.7K$775.3K
Net Income-$14.48M-$12.47M-$16.03M$13.47M$7.22M$2.14M-$81.18M-$13.60M-$1.19M-$198.9K
EPS (Diluted)$-0.04$-0.03$-0.04$0.04$0.02$0.01$-0.39
Total Assets$202.56M$206.99M$196.12M$152.20M$123.20M$76.45M$61.57M$82.96M$32.20M$8.56M
Total Liabilities$137.83M$129.44M$107.21M$57.17M$49.18M$53.62M$55.24M$21.20M$21.19M$9.11M
Shareholders' Equity$50.01M$58.55M$68.89M$57.31M$36.30M$8.10M$6.33M$61.76M$11.01M-$551.4K
Cash & Equivalents$7.28M$14.64M$9.74M$29.68M$3.00M$738.7K$4.10M$1.29M$569.4K
Operating Cash Flow$7.70M$6.79M$7.91M$7.31M$35.85M$3.38M-$24.14M-$2.91M$1.76M-$197.9K
Capital Expenditures$1.17M$11.96M$20.13M$12.14M$17.87M$4.69M$9.67M$8.92M$20.98M$3.36M
Shares Outstanding396.91M381.48M375.13M341.47M334.03M314.42M228.41M211.01M176.85M64.07M